Cargando…

Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study

Although initial serum albumin level is highly associated with overall and cardiovascular mortality in peritoneal dialysis (PD) patients, we consider that the dynamic change and trend of albumin after initiation of PD are also essential. We enrolled patients who received PD for more than 3 months fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Ping-Fang, Tsai, Chun-Chieh, Wu, Chia-Lin, Yang, Tse-Yen, Liou, Hung-Hsiang, Chen, Hung-Lin, Kor, Chew-Teng, Chang, Chia-Chu, Chang, Horng-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998418/
https://www.ncbi.nlm.nih.gov/pubmed/27015223
http://dx.doi.org/10.1097/MD.0000000000003202
_version_ 1782449938231197696
author Chiu, Ping-Fang
Tsai, Chun-Chieh
Wu, Chia-Lin
Yang, Tse-Yen
Liou, Hung-Hsiang
Chen, Hung-Lin
Kor, Chew-Teng
Chang, Chia-Chu
Chang, Horng-Rong
author_facet Chiu, Ping-Fang
Tsai, Chun-Chieh
Wu, Chia-Lin
Yang, Tse-Yen
Liou, Hung-Hsiang
Chen, Hung-Lin
Kor, Chew-Teng
Chang, Chia-Chu
Chang, Horng-Rong
author_sort Chiu, Ping-Fang
collection PubMed
description Although initial serum albumin level is highly associated with overall and cardiovascular mortality in peritoneal dialysis (PD) patients, we consider that the dynamic change and trend of albumin after initiation of PD are also essential. We enrolled patients who received PD for more than 3 months from January 1999 to March 2014. We categorized these patients into 2 groups by the difference in serum albumin level (Δalbumin = difference between peak with initial albumin level = peak albumin level − initial albumin level) after PD. The patients with Δalbumin < 0.2 g/dL (median level) were considered as group A (n, number = 238) and those with Δalbumin ≥ 0.2 g/dL were considered as group B (n = 278). Further, we stratified these patients into quartiles: Q1 Δalbumin < −0.2 g/dL; Q2, −0.2 ≦∼ <0.2 g/dL; Q3, 0.2 ≦∼ <0.6 g/dL; and Q4, ≥0.6 g/dL. Regression analysis was performed to determine the correlation of initial albumin and Δalbumin. Group A patients presented with higher levels of serum albumin (3.71 ± 0.54 vs 3.04 ± 0.55 g/dL; P < 0.001) and hematocrit as well as better initial residual renal function. However, those in group A had lower serum albumin increment and downward-sloped trends after dialysis. In contrast, the albumin trend was upward sloped and the increment of albumin was remarkable in group B, despite the high prevalence of cardiovascular diseases and diabetes. Overtime, group A patients had poorer survival and experienced more frequent and longer hospitalizations. Group Q1 patients with least albumin increment had worst survival. Group Q4 patients with lowest initial albumin also had poor survival. Age, diabetes, cardiovascular diseases, BMI, initial albumin, and Δalbumin could affect patient outcomes independently. Regression analysis showed a better outcome can be obtained if the initial albumin level is at least above 3.15 g/dL. (Initial albumin level = −0.61 × Δalbumin + 3.50.) The increment and trend of albumin especially during early period of PD may be a more crucial determinant for survival.
format Online
Article
Text
id pubmed-4998418
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49984182016-09-02 Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study Chiu, Ping-Fang Tsai, Chun-Chieh Wu, Chia-Lin Yang, Tse-Yen Liou, Hung-Hsiang Chen, Hung-Lin Kor, Chew-Teng Chang, Chia-Chu Chang, Horng-Rong Medicine (Baltimore) 5200 Although initial serum albumin level is highly associated with overall and cardiovascular mortality in peritoneal dialysis (PD) patients, we consider that the dynamic change and trend of albumin after initiation of PD are also essential. We enrolled patients who received PD for more than 3 months from January 1999 to March 2014. We categorized these patients into 2 groups by the difference in serum albumin level (Δalbumin = difference between peak with initial albumin level = peak albumin level − initial albumin level) after PD. The patients with Δalbumin < 0.2 g/dL (median level) were considered as group A (n, number = 238) and those with Δalbumin ≥ 0.2 g/dL were considered as group B (n = 278). Further, we stratified these patients into quartiles: Q1 Δalbumin < −0.2 g/dL; Q2, −0.2 ≦∼ <0.2 g/dL; Q3, 0.2 ≦∼ <0.6 g/dL; and Q4, ≥0.6 g/dL. Regression analysis was performed to determine the correlation of initial albumin and Δalbumin. Group A patients presented with higher levels of serum albumin (3.71 ± 0.54 vs 3.04 ± 0.55 g/dL; P < 0.001) and hematocrit as well as better initial residual renal function. However, those in group A had lower serum albumin increment and downward-sloped trends after dialysis. In contrast, the albumin trend was upward sloped and the increment of albumin was remarkable in group B, despite the high prevalence of cardiovascular diseases and diabetes. Overtime, group A patients had poorer survival and experienced more frequent and longer hospitalizations. Group Q1 patients with least albumin increment had worst survival. Group Q4 patients with lowest initial albumin also had poor survival. Age, diabetes, cardiovascular diseases, BMI, initial albumin, and Δalbumin could affect patient outcomes independently. Regression analysis showed a better outcome can be obtained if the initial albumin level is at least above 3.15 g/dL. (Initial albumin level = −0.61 × Δalbumin + 3.50.) The increment and trend of albumin especially during early period of PD may be a more crucial determinant for survival. Wolters Kluwer Health 2016-03-25 /pmc/articles/PMC4998418/ /pubmed/27015223 http://dx.doi.org/10.1097/MD.0000000000003202 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5200
Chiu, Ping-Fang
Tsai, Chun-Chieh
Wu, Chia-Lin
Yang, Tse-Yen
Liou, Hung-Hsiang
Chen, Hung-Lin
Kor, Chew-Teng
Chang, Chia-Chu
Chang, Horng-Rong
Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study
title Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study
title_full Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study
title_fullStr Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study
title_full_unstemmed Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study
title_short Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study
title_sort trajectories of serum albumin predict survival of peritoneal dialysis patients: a 15-year follow-up study
topic 5200
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998418/
https://www.ncbi.nlm.nih.gov/pubmed/27015223
http://dx.doi.org/10.1097/MD.0000000000003202
work_keys_str_mv AT chiupingfang trajectoriesofserumalbuminpredictsurvivalofperitonealdialysispatientsa15yearfollowupstudy
AT tsaichunchieh trajectoriesofserumalbuminpredictsurvivalofperitonealdialysispatientsa15yearfollowupstudy
AT wuchialin trajectoriesofserumalbuminpredictsurvivalofperitonealdialysispatientsa15yearfollowupstudy
AT yangtseyen trajectoriesofserumalbuminpredictsurvivalofperitonealdialysispatientsa15yearfollowupstudy
AT liouhunghsiang trajectoriesofserumalbuminpredictsurvivalofperitonealdialysispatientsa15yearfollowupstudy
AT chenhunglin trajectoriesofserumalbuminpredictsurvivalofperitonealdialysispatientsa15yearfollowupstudy
AT korchewteng trajectoriesofserumalbuminpredictsurvivalofperitonealdialysispatientsa15yearfollowupstudy
AT changchiachu trajectoriesofserumalbuminpredictsurvivalofperitonealdialysispatientsa15yearfollowupstudy
AT changhorngrong trajectoriesofserumalbuminpredictsurvivalofperitonealdialysispatientsa15yearfollowupstudy